- Trials with a EudraCT protocol (24)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (8)
24 result(s) found for: Artificial Tear.
Displaying page 1 of 2.
EudraCT Number: 2022-002434-13 | Sponsor Protocol Number: 01-INSULINAGLAUCOMA-2022 | Start Date*: 2023-01-18 |
Sponsor Name:Barbara Burgos-Blasco | ||
Full Title: RANDOMIZED CLINICAL TRIAL DOUBLE BLIND (WITH BLIND EVALUATOR) TO DETERMINE THE EFFECTIVENESS AND SAFETY OF TOPICAL INSULIN IN THE TREATMENT OF DRY EYE IN PATIENTS WITH TOPICAL HYPOTENSIVE DRUGS | ||
Medical condition: Dry eye disease in glaucoma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004271-12 | Sponsor Protocol Number: NGF0213 | Start Date*: 2014-01-17 | |||||||||||
Sponsor Name:Dompé s.p.a | |||||||||||||
Full Title: An open-label study evaluating safety and efficacy of recombinant human nerve growth factor (rhNGF) eye drops at different doses in patients with Dry Eye | |||||||||||||
Medical condition: Dry Eye syndrome is caused by either decreased tear production or increased tear film evaporation. Dry eye is a chronic inflammatory condition of the ocular surface with severe symptoms and visual ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004605-27 | Sponsor Protocol Number: Occhuiosecco | Start Date*: 2012-11-05 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA | |||||||||||||
Full Title: Study Prospective Randomized Controlled Double-Blind: Comparison of tear substitute (Siccafluid) and Autologous Serum in Dry Eye Disease | |||||||||||||
Medical condition: Dry eye disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002183-63 | Sponsor Protocol Number: IOBA-CERLab-003-2013 | Start Date*: 2013-11-12 | ||||||||||||||||
Sponsor Name:IOBA | ||||||||||||||||||
Full Title: Unicenter, double masked, crossover clinical trial to assess the efficacy of FML (0.1% Fluorometolone) in dry eye patients | ||||||||||||||||||
Medical condition: Dry eye syndrome (DES) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000982-19 | Sponsor Protocol Number: IOBA-ImmunEyez_011-2018 | Start Date*: 2019-12-11 |
Sponsor Name:Instituto de Oftalmobiología Aplicada (IOBA) | ||
Full Title: A Phase IV Open-Label Clinical Trial to Evaluate the Efficacy of Ikervis® on Clinical Parameters and Molecular/Cellular Biomarkers in Dry Eye Patients with Severe Keratitis who have not improved de... | ||
Medical condition: Dry eye disease with severe keratitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003285-27 | Sponsor Protocol Number: T1565-PIV-0117 | Start Date*: 2017-09-26 | |||||||||||
Sponsor Name:Laboratoires Thea | |||||||||||||
Full Title: Clinical efficacy of topical hydrocortisone 0.335% (Softacort®) in patients with chronic dry eye disease and associated ocular surface inflammation | |||||||||||||
Medical condition: Dry Eye Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006801-31 | Sponsor Protocol Number: 01-INSULINAOJOSECO-2021 | Start Date*: 2022-07-04 |
Sponsor Name:Barbara Burgos-Blasco | ||
Full Title: RANDOMIZED PARALLEL CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS AND SAFETY OF TOPICAL INSULIN IN THE TREATMENT OF DRY EYE IN PATIENTS WITH DRY EYE | ||
Medical condition: Dry eye disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005160-18 | Sponsor Protocol Number: RP101-200 | Start Date*: 2018-12-18 | |||||||||||
Sponsor Name:Redwood Pharma AB | |||||||||||||
Full Title: A Phase II, multicentre, randomised, placebo-controlled, double-masked trial of RP101 ophthalmic formulation versus vehicle in post-menopausal women with moderate to severe dry eye syndrome | |||||||||||||
Medical condition: moderate or severe dry eye syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) HU (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000029-23 | Sponsor Protocol Number: NVG06C103 | Start Date*: 2008-10-16 | |||||||||||
Sponsor Name:Novagali Pharma S.A. | |||||||||||||
Full Title: A Phase III, Multicenter, Randomized, Controlled, Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Ophthalmic Cationic Emulsion versus Vehicle in Patients with Moderate to Severe Dry Eye Syndrome | |||||||||||||
Medical condition: Keratoconjunctivitis sicca (KCS), or dry eye syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) FR (Completed) ES (Completed) IT (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000480-41 | Sponsor Protocol Number: FARM6AS8AW | Start Date*: 2008-05-27 | |||||||||||
Sponsor Name:UNIVERSITA' CAMPUS BIOMEDICO | |||||||||||||
Full Title: Multicenter, randomised, double masked, controlled clinical trial on the safety and efficacy of Cyclosporine A eye drop treatment on patients with ocular cicatricial pemphigoid. | |||||||||||||
Medical condition: Ocular cicatricial pemphigoid (OCP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003326-13 | Sponsor Protocol Number: BTI-011-EC/15/QUER | Start Date*: 2016-01-05 |
Sponsor Name:BTI Biotechnology Institute I mas D | ||
Full Title: Randomized, parallel groups, multicenter and blind to evaluators clinical trial, to evaluate the efficacy and safety of PRGF-Endoret eye drops, in patients with stage 2 and 3 neurotrophic keratitis. | ||
Medical condition: Neurotrophic Keratitis (NK) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000937-54 | Sponsor Protocol Number: MC2-03-C1 | Start Date*: 2015-08-03 | ||||||||||||||||
Sponsor Name:DRUG DELIVERY SOLUTIONS ApS (PART OF MC2 BIOTEK GROUP) | ||||||||||||||||||
Full Title: A phase II, multicenter, randomized, double-masked, 4 parallel arms, controlled 6-month trial designed to evaluate the safety and efficacy of PAD ciclosporin (CsA 0.06% and 0.03%) ophthalmic disper... | ||||||||||||||||||
Medical condition: ocular dryness (Dry Eye Disease - DED) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) DK (Completed) NO (Completed) AT (Completed) ES (Completed) PT (Completed) FR (Completed) SK (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-003469-36 | Sponsor Protocol Number: THEA_HLF_1/21 | Start Date*: 2021-09-17 | ||||||||||||||||
Sponsor Name:Laboratorios Théa, S.A. | ||||||||||||||||||
Full Title: “Prospective evaluation of the efficacy and safety of topical hydrocortisone treatment on clinical signs and symptoms of dry eye disease associated with moderate meibomian gland dysfunction” | ||||||||||||||||||
Medical condition: Dry Eye (DE) and Meibomian gland dysfunction (MGD) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003497-40 | Sponsor Protocol Number: NVG16E128 | Start Date*: 2016-12-28 | |||||||||||
Sponsor Name:SANTEN SAS | |||||||||||||
Full Title: A PHASE IV, PROSPECTIVE, OPEN-LABEL, MULTICENTRE, SINGLE ARM, 3-MONTH PROOF OF CONCEPT STUDY TO ASSESS THE EFFECT OF IKERVIS® 1MG/ML (CICLOSPORIN) EYE DROPS ADMINISTERED ONCE DAILY ON THE QUALITY O... | |||||||||||||
Medical condition: Effect of one eye drop of IKERVIS®on adult male or female (aged 18 years or above) Dry Eye Disease patients with severe keratitis despite the use of tear substitutes. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003346-21 | Sponsor Protocol Number: NGF0121 | Start Date*: 2021-11-24 | |||||||||||
Sponsor Name:DOMPé FARMACEUTICI S.P.A. | |||||||||||||
Full Title: A 4 week, Phase III, multicenter, double-masked, vehicle-controlled study to evaluate safety and efficacy of Oxervate® (cenegermin) 20 mcg/mL ophthalmic solution versus vehicle, in patients with se... | |||||||||||||
Medical condition: Severe Sjogren’s dry eye disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000160-97 | Sponsor Protocol Number: NVG10E117 | Start Date*: 2011-04-08 | ||||||||||||||||||||||||||
Sponsor Name:NOVAGALI Pharma S.A. | ||||||||||||||||||||||||||||
Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-MASKED, 2 PARALLEL ARM, VEHICLE CONTROLLED, 6-MONTH PHASE III TRIAL WITH A 6 MONTH OPEN LABEL TREATMENT SAFETY FOLLOW-UP PERIOD TO EVALUATE THE EFFICACY AND SAFETY... | ||||||||||||||||||||||||||||
Medical condition: Severe Dry Eye Disease | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SE (Completed) BE (Completed) DE (Completed) IT (Ongoing) AT (Completed) GB (Completed) CZ (Completed) ES (Ongoing) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002238-35 | Sponsor Protocol Number: 11002X-001 | Start Date*: 2012-10-04 | |||||||||||
Sponsor Name:Allergan Ltd. | |||||||||||||
Full Title: A Multicenter, Double-masked, Randomized Study to Compare the Safety and Efficacy of an Investigational Eye Drop Formulation with OPTIVE™ Unit-Dose for 3 Months in Subjects with Dry Eye Disease | |||||||||||||
Medical condition: Dry Eye Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) DE (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002660-41 | Sponsor Protocol Number: NVG14L127 | Start Date*: 2019-04-29 | |||||||||||
Sponsor Name:SANTEN SAS | |||||||||||||
Full Title: A Phase IIIb, prospective, interventional, multicentre, three-year study to explore the long-term evolution of sign and symptoms, and occurrence of complications in Dry Eye Disease patients with se... | |||||||||||||
Medical condition: DRY EYE DISEASE WITH SEVERE KERATITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) PL (Completed) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003903-79 | Sponsor Protocol Number: SYL1001_IV | Start Date*: 2017-07-24 | |||||||||||
Sponsor Name:Sylentis SAU - PharmaMar Group | |||||||||||||
Full Title: A double-masked study of SYL1001 in patients with moderate to severe dry eye disease (DED) | |||||||||||||
Medical condition: Moderate to severe dry eye disease (DED) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) PT (Completed) EE (Completed) SK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002835-40 | Sponsor Protocol Number: AK701 | Start Date*: 2020-01-28 | ||||||||||||||||||||||||||
Sponsor Name:Akari Therapeutics Plc | ||||||||||||||||||||||||||||
Full Title: Topical rVA576 for treatment of atopic keratoconjunctivitis: a randomised placebo double masked parallel trial (TRACKER) | ||||||||||||||||||||||||||||
Medical condition: Moderate to severe atopic keratoconjunctivitis (AKC), Vernal keratoconjunctivitis (VKC), Severe allergic conjunctivitis (seasonal (SAC) or perennial (PAC)) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.